David Krakow
Psychosomatic Medicine · New York, NYNPI 1962629188
Payments from drug & device makers
Across 426 payments — averaging $8721.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sage Therapeutics, LLC$1.5M
- Otsuka Pharmaceutical Development & Commercialization, Inc.$626K
- Axsome Therapeutics, Inc.$440K
- AbbVie$408K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$367K
- F. Hoffmann-la Roche AG$134K
- plus $275K from 12 others
Across 29 payments — averaging $4548.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arbor Pharmaceuticals, Inc.$114K
- Purdue Pharma L.p.$16K
- Supernus Pharmaceuticals, Inc.$2K
What the payments were for
- Food & beverage$644100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sage Therapeutics, LLC | 79 | $1,465,514 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 14 | $625,687 |
| Axsome Therapeutics, Inc. | 27 | $440,230 |
| AbbVie(2 entities) | 140 | $408,164 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 47 | $366,534 |
| F. Hoffmann-la Roche AG | 13 | $133,813 |
| Janssen Research & Development, LLC | 24 | $110,527 |
| Supernus Pharmaceuticals, Inc. | 32 | $71,574 |
| Sunovion Pharmaceuticals Inc. | 28 | $59,436 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $26,099 |
| Adlon Therapeutics L.p. | 1 | $6,000 |
| Biohaven Pharmaceuticals, Inc. | 1 | $1,250 |
| Johnson & Johnson | 1 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $114 |
| Vertical Pharmaceuticals, LLC | 4 | $86 |
| Neos Therapeutics, LP | 2 | $45 |
| Bausch Health US, LLC | 2 | $45 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$123
How this compares
$3,715,261 in reported general payments places this provider in the 95th percentile of 30 psychosomatic medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XanaxAlprazolam | 12 | $9,161 |
| Methylphenidate Hcl | 12 | $735 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 38 | $646 |
| Duloxetine Hcl | 31 | $619 |
| Buspirone Hcl | 11 | $584 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $462 |
| Bupropion XlBupropion Hcl | 12 | $435 |
| Clonazepam | 92 | $411 |
| Sertraline Hcl | 42 | $250 |
| Fluoxetine Hcl | 11 | $192 |
| Propranolol Hcl | 18 | $121 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $84 |
| Trazodone Hcl | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other psychosomatic medicine in New York
- Zorica Filipovic-JewellNew York$653
- Diana PunkoNew York$572
- Jena AndreuNew York$320
- Flavia RobottiNew York$258
- Daniel SafinNew York$234
- Deborah FinklesteinNew York$205
- Akhil ShenoyNew York$157
- Allison DeutchNew York$150
- Roger WolfsohnNew York$125
- Sharon FingerothNew York$114
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.